PLX4032 (Vemurafenib) Mechanism of Action: BRAF Inhibition in Melanoma Cell Research

PLX4032 (Vemurafenib) MOA:Targeting BRAF/MAPK Pathway for Metastatic Melanoma

🎯 check PLX4032 (Vemurafenib) product page

Vemurafenib is a potent and selective BRAFV600E kinase inhibitor. It affects the MAPK/ERK signaling pathway by blocking MEK and ERK phosphorylation, effectively inhibiting cell proliferation and migration, and inducing apoptosis in BRAF-mutated cancer cells.

Primary Applications and Mechanism of Action